Coronary artery calcium (CAC) scoring and traditional risk factor assessment via pooled cohort equations yield similar rates of major cardiovascular events when used to guide statin initiation for primary prevention, according to clinical trial results presented at the European Society of Cardiology Congress. Cardiovascular diseases remain the leading global cause of morbidity and mortality, driven largely by atherosclerotic cardiovascular disease, which encompasses coronary artery disease and ischemic stroke.
CorCal Outcomes Trial Design and Patient Demographics
The CorCal Outcomes trial evaluated 5,772 patients to compare two distinct methods for selecting individuals for preventative statin therapy. According to study data, participants had a mean age of 64 years and 51% were women. Researchers enrolled patients without known atherosclerotic cardiovascular disease, diabetes, or prior statin history who were registered with Intermountain Health Care in the Canyons and Desert regions of the United States.
Patients were randomized on a 1:1 basis to receive statin initiation guidance derived either from pooled cohort equations based on traditional risk factors or from coronary artery calcium measurement via computed tomography scan. Participants and their physicians received protocol-directed recommendations based on these scores, leaving final treatment decisions to the individual care teams. The primary endpoint tracked major cardiovascular events, defined as all-cause mortality, myocardial infarction, stroke, and arterial revascularisation.
Statin Initiation Rates and Medication Adherence Disparities
After a follow-up period of 4.2 years, major cardiovascular events occurred in 2.7% of patients across both trial arms. According to the data, the noninferiority criterion was not met, yielding a hazard ratio of 0.99 with a 95% confidence interval ranging from 0.71 to 1.38 and a p-value of 0.045 for noninferiority.
Substantial differences emerged in prescription recommendations and patient compliance between the two strategies. Patients randomized to the pooled cohort equations group received recommendations to start statins more than three times as frequently as those in the coronary artery calcium group. However, patients who received statin recommendations based on their coronary artery calcium score demonstrated markedly higher medication adherence, at 62%, compared with 23% in the risk factor group.
Expert Analysis on Trial Power and Future Guidelines
Doctor Joseph B Muhlestein of the Intermountain Medical Center in Murray, USA, who served as Principal Investigator for the trial, noted that lower-than-expected event rates reduced the study’s statistical power to detect a difference between the strategies. Standard risk evaluation methods often fail to flag many people—specifically younger patients undergoing a first heart attack—as having high enough danger levels to justify statin treatment.
Doctor Muhlestein noted that the trial successfully yielded valuable insights for generating hypotheses concerning statin adoption efficiency and compliance when utilizing CAC metrics to drive choices. He proposed that the gathered information might serve to design another robust, well-powered randomized trial pitting CAC against prevailing risk-factor algorithms. At the same time, the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidemias incorporates an advisory suggesting that elevated subclinical atherosclerosis indicated by a higher CAC score, if tested, ought to function as a modifying risk factor for patients falling into moderate-risk categories or sitting near thresholds for treatment choices.
Pro Tip: When evaluating primary prevention strategies, clinicians look at both plaque burden via computed tomography and traditional modifiable risk factors like smoking, diabetes, hypertension, and high cholesterol levels to tailor interventions effectively.
Frequently Asked Questions
What is coronary artery calcium scoring?
Coronary artery calcium scoring is an assessment of coronary plaque burden performed using a computed tomography scan to help evaluate cardiovascular risk.
What did the CorCal Outcomes trial investigate?
According to researchers, the trial compared pooled cohort equations based on traditional risk factors against coronary artery calcium measurement for selecting patients to receive statin therapy to prevent a first cardiovascular event.
How did patient adherence differ between the two methods?
Patients who received statin recommendations based on their coronary artery calcium score had a 62% medication adherence rate, compared to 23% among patients guided by traditional risk factor equations.
What are the main modifiable risk factors for atherosclerotic cardiovascular disease?
Key modifiable risk factors include smoking, diabetes, hypertension, and high cholesterol levels.
Want to stay updated on the latest cardiovascular research and clinical trial outcomes from major medical congresses? Subscribe to our newsletter today or explore more articles on our website.
Related reading